Per agreement AlphaSigma will cover the entire cost of B foam/cream development AND the entire cost of next B-UP/UPS trial. So we got a good deal based on robust results per our small PoC. Next trial could value us in the billions.

As reported "The initial payment will help cover substantially the costs of our upcoming clinical study of oral-dosed Brilacidin currently being developed for treating Ulcerative Colitis (UC). This first clinical trial, evaluating Brilacidin in oral tablet form, is targeted to commence later this year or early thereafter".